289 Correlation between physical activity and control of cardiovascular risk factors in 233 patients with stable angina. Results of a monocentric prevalence study  by Penot, Jean-Patrick
© Elsevier Masson SAS. All rights reserved.
 
94 Archives of Cardiovascular Diseases Supplements (2010) 2, 91-99
289
Correlation between physical activity and control of cardiovascular
risk factors in 233 patients with stable angina. Results of a monocen-
tric prevalence study
Jean-Patrick Penot
Polyclinique St Georges, St Georges De Didonne, France
Euroaspire III shows a worse control of risk factors in a European popula-
tion with coronary artery disease (CAD). The aim of this monocentric preva-
lence study was to evaluate benefits of a persistent physical activity (ϕA) in a
stable angina population.
Method: 233 consecutive patients (pts) with documented CAD were
included between November 2008 and March 2009. This population was
divided in 2 groups (Gp) according to weekly time of ϕA (cycle, walking or
swimming). Past history of CAD, treatment, resting heart rate, blood pressure
(BP), Body Mass Index (BMI), waist circumference (WC), diabetes and lipid
status were noted.
Result: 
Conclusion: 1° control of classic cardiovascular risk factors is conform to
actual recommendations but ϕA is insufficient. 2° 50% of patients stop ϕA
after cardiac rehabilitation 3° ϕA is associated with a best treatment and past
history of NSTE-ACS. 4° prolonged ϕA more than 1.5 hours per week is pos-
sible out of all protocol. 5° ϕA is associated with a signficative best control of
cardiovascular risk factors in a stable CAD population (resting heart rate,
BMI, lipid status, smoking) and must be regarded as a good marker of preven-
tive behavior.
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Efficacy of diet change on short-term glucometabolic state evolution
measured by OGTT in patients after an Acute Coronary Syndrome
Marianne Lafitte, Yann Pucheu, Vincent Pradeau, Armelle Machet,
Thierry Couffinhal
CHU bordeaux, CEPTA hôpital cardiologique, Pessac, France
Background: Patients with acute coronary syndrome (ACS) have a high
prevalence of previously unknown diabetes mellitus (DM) and impaired glu-
cose tolerance (IGT). Both conditions represent strong risk factors for future
cardiovascular events after ACS.
Aim: to evaluate, in non-diabetic patients in post-ACS, the effect of an
early diagnosis and management of glucose metabolism abnormalities, on their
persistence at 3-month.
Patients and methods: 271 consecutive patients were admitted for an
ACS. OGTT was performed at day 2-4, and risk factors were recorded.
Patients were classified following OGTT. All subjects received 3 educational
courses for lifestyle modification (diet, smoking, and physical activity). Glu-
cometabolic state was again assessed three months after the ACS.
Results: DM was known or diagnosed in 29.5% of the patients at admis-
sion for ACS. Patients with normal fasting glucose but classified as New Dia-
betes (ND, 16,7%) on OGTT shared the same risk factor profile and atheroma
burden as DM patients. IGT patients (28,3%) displayed risk values in-between
NGT and ND patients.
Lifestyle modifications after 3 months were effective. Food records found
that energy intake and fat intake decreased significantly through 3 months,
with a significant increase in mono and poly unsaturated fat and a significant
decrease in saturated fat. Triglycerides and metabolic syndrome were
reduced, HDL cholesterol increased. As shown by OGTT results at 3
months, 70% of IGT patients at 3 days were classified as NGT at 3 months.
More than 50% of the ND group at 3 days was re-classified as IGT or NGT
at 3 months.
Conclusion: An OGTT performed after an ACS, associated with lifestyle
modification and diet intervention significantly improved the short-term evo-
lution of the glucometabolic state.
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An active strategy based on mandatory nicotine replacement coupled
with a behavioral approach can dramatically decrease the rate of
smoking 6 months after an acute coronary syndrome. The PATPAC
trial
Gally Olivia (1), Laurent Magne (1), Yasmina Bouchemha (2), Jean
Guillaume Dillinger (2), Georgios Sideris (2), Patrick Henry (2)
(1) Psychologue, Paris, France – (2) APHP – Lariboisiere, Cardiologie,
Paris, France
Background: Although smoking continuation after an acute coronary syn-
drome (ACS) is associated with a poor prognosis, in-hospital smoking cessa-
tion strategies for such patients are not well defined. We evaluated an in-
hospital initiated smoking cessation program based on mandatory nicotine
replacement and a cognitive behavioral approach in ACS patients.
Methods: All consecutive eligible active smoker patients (mean >5 cig/
day) hospitalized for ACS in our CCU were included. Main exclusion criteria
were unstable hemodynamic status, the presence of another dependence
(mainly alcohol or drug) and planned re-hospitalization after discharge. The
patients were randomized into two groups: an active group receiving manda-
tory nicotine replacement on day 1 after hospitalization coupled with a behav-
ioral approach based on “exposure” on day 2 and 3 and after discharge on
week 1, 2, 3, 4 and month 3; a control group where patients received coun-
seling and were proposed nicotine replacement during hospitalization. The
main endpoint was the rate of non-smoking patients in each group (self-decla-
ration + CO measurement) at 6 months after inclusion.
Results: 52 patients were studied: 25 (mean age 51± 7 y.o., 76% male) in
the active group and 27 (mean age 54 ± 8 y.o. 100% male) in the control
group. In the active and control groups respectively, mean duration of smoking
was 31 ± 9 and 35 ± 9 years, mean number of cigarettes/day 24 ± 6 and 23 ±
10, Fargeström score 5.0 ±2.0 and 5.4±2.4, anxiety and depression score
(HAD) 13.8± 6.9 and 14.4 ± 4.8, and BMI 26 ± 3 and 27±3 (all NS). After 6
months, 41.7% patients had stopped smoking in the control group as compared
to 85.0% in the active grouo.
Conclusion: A strategy based on mandatory nicotine replacement coupled
with a behavioral approach can markedly decrease the rate of smoking in
patients 6 months after ACS. The impact of such a strategy on major cardiac
events as secondary prevention in smokers remains to be evaluated.
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Mean age±SD
Sex ratio
129
71±10
107/22
104
72±10*
79/25
SA
NSTE-ACS
STE-ACS
coronary artery bypass grafting
Cardiac rehabilitation
25%
5%
26%
12%
22%
27%
35%*
38%*
23%*
25%
Betablockers
Antiplatelet therapy
Statin
ACE inhibitors
77%
98%
90%
65%
70%
87%**
79% £
73%
Smoker 5% 13%*
Resting heart rate (bpm)
Systolic/disatolic BP (mmHg)
66±11
135±18/75±10
68±12 £
135±18/74±10
BMI (kg.m-2)
WC men (cm)
WC women (cm)
Triglycerid (mg.dl-1)
27.1±4.4
100±12
91±13
1.2±0.5
27.9±4.8*
104±12**
93±12
1.3±0.6
Diabetes
HbA1c (%)
20%
6.8±1.7
24%
7.2±1.5
LDL-cholesterol (mg.dl-1) 0.9±0.3 1.0±0.4*
acute coronary syndromes (ACS), non-ST-segment elevation (NSTE), 
Stable angina (SA), Standard deviation (SD), ST-segment elevation (STE), 
* p<0.05, ** p<0.01, £ p<0.001
